Please log in to view this page
Username
Password
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
